Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-06 Purchase | 2022-09-07 8:14 pm | Liquidia Corp | LQDA | JEFFS ROGER CEO | 43,820 | $5.568 | $243,990 | 1,748,089 (Indirect Direct) | View |
| 2022-08-31 Purchase | 2022-09-01 8:36 pm | Liquidia Corp | LQDA | JEFFS ROGER CEO | 993 | $4.9045 | $4,870 | 1,704,269 (Indirect Direct) | View |
| 2022-05-24 Purchase | 2022-05-25 7:27 pm | Liquidia Corp | LQDA | JEFFS ROGER CEO | 28,000 | $3.529 | $98,812 | 1,703,276 (Indirect Direct) | View |
| 2021-11-19 Purchase | 2021-11-23 07:30 am | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 3,950 | $37.3 | $147,350 | 167,668 (Indirect Direct) | View |
| 2021-04-13 Purchase | 2021-04-15 09:22 am | Liquidia Corp | LQDA | JEFFS ROGER Director | 99,206 | $2.52 | $249,999 | 1,505,301 (Indirect Direct) | View |
| 2019-07-01 Sale | 2019-07-02 4:58 pm | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 1,308 | $14.17 | $18,534 | 66,993 (Direct) | View |
| 2018-12-19 Purchase | 2018-12-21 5:12 pm | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 30,000 | $6.2212 | $186,635 | 61,400 (Direct) | View |
| 2018-09-07 Purchase | 2018-09-07 7:18 pm | SANGAMO THERAPEUTICS INC | SGMO | JEFFS ROGER Director | 7,408 | $13.56 | $100,487 | 9,908 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-03 Exercise | 2022-10-04 4:25 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER CEO | 47,423 | $0 | 1,811,319 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:34 pm | 2026-01-03 2032-06-17 | Liquidia Corp | LQDA | JEFFS ROGER CEO | 931,475 | $0 | 931,475 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-20 4:35 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER CEO | 154,167 | $0 | 1,659,468 (Indirect) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $0 | 2,347 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:05 pm | 2026-01-03 2032-01-03 | Liquidia Corp | LQDA | JEFFS ROGER CEO | 1,746,057 | $0 | 1,826,410 (Direct) | View |
| 2021-08-20 Option Award | 2021-09-01 5:25 pm | 2024-08-20 2031-08-20 | Liquidia Corp | LQDA | JEFFS ROGER Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 4:05 pm | N/A 2031-06-23 | ALBIREO PHARMA Inc | ALBO | JEFFS ROGER Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:52 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 7,325 | $0 | 7,325 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-26 4:06 pm | N/A 2031-03-24 | Liquidia Corp | LQDA | JEFFS ROGER Director | 30,353 | $0 | 30,353 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:45 pm | 2021-03-05 2031-03-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,463 | $0 | 1,463 (Direct) | View |
| 2020-11-18 Other | 2020-11-19 4:11 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Director | 1,387,500 | $6 | 2,823,595 (Indirect) | View |
| 2020-11-18 Option Award | 2020-11-19 4:11 pm | N/A 2030-11-18 | Liquidia Corp | LQDA | JEFFS ROGER Director | 30,000 | $0 | 2,823,595 (Direct) | View |
| 2020-11-18 Ownership | 2020-11-19 4:06 pm | N/A N/A | Liquidia Corp | LQDA | JEFFS ROGER Director | 0 | $0 | 18,595 (Direct) | View |
| 2020-06-19 Option Award | 2020-06-19 6:09 pm | N/A 2030-06-18 | ALBIREO PHARMA Inc | ALBO | JEFFS ROGER Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-05 6:41 pm | 2021-06-05 2030-06-05 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 9:18 pm | 2020-03-17 2030-03-16 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 4,496 | $0 | 4,496 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 9,127 | $9 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 5,193 | $8.02 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 34,866 | $12.95 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | 2016-11-19 2025-11-18 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 60,186 | $0 | 163,718 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:08 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 11,000 | $4.95 | 163,718 (Direct) | View |
| 2019-11-12 Disposition | 2019-11-12 4:36 pm | N/A 2027-05-24 | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 109,993 | $0 | 0 (Direct) | View |
| 2019-07-03 Exercise | 2019-07-05 07:00 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 3,672 | $3.67 | 110,876 (Direct) | View |
| 2019-07-03 Exercise | 2019-07-05 07:00 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 39,948 | $2.85 | 110,876 (Direct) | View |
| 2019-07-03 Exercise | 2019-07-05 07:00 am | N/A 2024-09-15 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 56,620 | $0 | 110,876 (Direct) | View |
| 2019-07-03 Exercise | 2019-07-05 07:00 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $3.45 | 110,876 (Direct) | View |
| 2019-06-21 Option Award | 2019-06-25 4:49 pm | N/A 2029-06-20 | ALBIREO PHARMA Inc | ALBO | JEFFS ROGER Director | 5,500 | $0 | 5,500 (Direct) | View |
| 2019-06-07 Option Award | 2019-06-10 6:20 pm | 2020-06-07 2029-06-07 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2019-04-26 Option Award | 2019-04-30 4:34 pm | N/A 2029-04-25 | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-04-15 Option Award | 2019-04-17 9:11 pm | N/A 2029-04-14 | Axovant Sciences Ltd. | AXGT | JEFFS ROGER Director | 255,000 | $0 | 255,000 (Direct) | View |
| 2019-03-19 Option Award | 2019-03-21 4:06 pm | 2019-03-19 2029-03-18 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 34,866 | $0 | 34,866 (Direct) | View |
| 2019-02-05 Option Award | 2019-02-07 4:59 pm | N/A N/A | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 6,901 | $0 | 68,301 (Direct) | View |
| 2018-06-19 Option Award | 2018-06-21 4:25 pm | N/A 2028-06-19 | Dova Pharmaceuticals Inc. | DOVA | JEFFS ROGER Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2018-06-15 Option Award | 2018-06-18 5:05 pm | N/A 2028-06-14 | ALBIREO PHARMA Inc | ALBO | JEFFS ROGER Director | 5,500 | $0 | 5,500 (Direct) | View |
| 2018-06-11 Option Award | 2018-06-12 8:25 pm | N/A 2028-06-10 | SANGAMO THERAPEUTICS INC | SGMO | JEFFS ROGER Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2018-06-08 Option Award | 2018-06-11 4:24 pm | N/A 2028-06-07 | ALBIREO PHARMA Inc | ALBO | JEFFS ROGER Director | 6,500 | $0 | 6,500 (Direct) | View |
| 2018-06-01 Option Award | 2018-06-05 8:21 pm | 2019-06-01 2028-06-01 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2018-03-12 Option Award | 2018-04-05 10:05 am | 2018-03-12 2028-03-11 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 39,948 | $0 | 39,948 (Direct) | View |
| 2018-02-13 Option Award | 2018-02-15 5:45 pm | N/A 2028-02-12 | Axovant Sciences Ltd. | AXON | JEFFS ROGER Director | 150,000 | $0 | 150,000 (Direct) | View |